Related Experiment Videos
RET mutation screening in sporadic pheochromocytoma
The Journal of Clinical Endocrinology and Metabolism
|January 1, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Telemedical aftercare of patients with skin diseases].
Dermatologie (Heidelberg, Germany)·2022
Childhood maltreatment is not associated with atopic dermatitis in adults: results from a cross-sectional population-based cohort study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Nosocomial or not? A combined epidemiological and genomic investigation to understand hospital-acquired COVID-19 infection on an elderly care ward.
Infection prevention in practice·2021
A method to assess heart rate variability in neonate rats: validation in normotensive and hypertensive animals.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2020
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Temple syndrome - an under-recognised multi-system growth disorder: large cohort analysis and proposed scoring system.
The Journal of clinical endocrinology and metabolism·2026
Management of Cirrhosis in Diabetes: A Pragmatic Approach to the Patient.
The Journal of clinical endocrinology and metabolism·2026
Gonadal MRI in Complete Androgen Insensitivity Syndrome: Pathologic Correlation and Low-Risk Features.
The Journal of clinical endocrinology and metabolism·2026
Cardiovascular morbidity and mortality in acromegaly-associated diabetes: a Swedish Nationwide study.
The Journal of clinical endocrinology and metabolism·2026
Decision Tree Prediction of Saline Infusion Test Outcomes in Suspected Primary Aldosteronism: A Multicenter CDM Study.
The Journal of clinical endocrinology and metabolism·2026
Belzutifan, A Hypoxia-Inducible Factor 2-Alpha Inhibitor, for Patients with Advanced Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026